Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 42 (RBM42) is a protein-coding gene encoding an RNA-binding protein that contains an RNA recognition motif (RRM) domain[1][5]. It binds RNA, specifically the 3'-untranslated region (UTR) of specific mRNAs such as CDKN1A, and is implicated in the regulation of mRNA splicing, acting as part of the spliceosomal tri-snRNP complex[1][3]. The protein functions primarily in post-transcriptional gene regulation, influencing the processing of capped, intron-containing pre-mRNA[1]. Diseases associated with RBM42 include Kleefstra syndrome 2 and TARP syndrome, but there is limited evidence linking it directly to therapeutic drug targeting in humans[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 42 (RBM42).